245 related articles for article (PubMed ID: 4443613)
1. Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine.
Cash RA; Music SI; Libonati JP; Craig JP; Pierce NF; Hornick RB
J Infect Dis; 1974 Oct; 130(4):325-33. PubMed ID: 4443613
[No Abstract] [Full Text] [Related]
2. [A study of immunological efficacy of the oral chemical cholera vaccine on experimental animals].
Dzhaparidze MN; Egorova VD; Karaeva LT; Sumarokov AA; Gor'kova Av
Zh Mikrobiol Epidemiol Immunobiol; 1976 Nov; (11):115-9. PubMed ID: 1007720
[TBL] [Abstract][Full Text] [Related]
3. [Determination of Vibrio antibody titers during anti-cholera vaccination].
Dirimci OT; Cinar V
Turk Hij Tecr Biyol Derg (1961); 1973; 33(2-3):118-28. PubMed ID: 4807572
[No Abstract] [Full Text] [Related]
4. [Reactogenicity and immunological effectiveness of an oral cholera chemical vaccine in a limited controlled experiment with human revaccination].
Sumarokov AA; Ivanov NR; Lelikov VL; Dzhaparidze MN; Karaeva LT
Zh Mikrobiol Epidemiol Immunobiol; 1978; (12):87-92. PubMed ID: 371293
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a live oral cholera vaccine in human volunteers.
Woodward WE; Gilman RH; Hornick RB; Libonati JP; Cash RA
Dev Biol Stand; 1976; 33():108-12. PubMed ID: 782960
[TBL] [Abstract][Full Text] [Related]
6. An oral cholera vaccine for travelers (Vaxchora).
Med Lett Drugs Ther; 2016 Aug; 58(1502):113-4. PubMed ID: 27552209
[No Abstract] [Full Text] [Related]
7. Synergistic protection against experimental cholera by immunization with cholera toxoid and vaccine.
Peterson JW
Infect Immun; 1979 Nov; 26(2):528-33. PubMed ID: 546785
[TBL] [Abstract][Full Text] [Related]
8. Neutralization of cholera enterotoxin-induced steroidogenesis by specific antibody.
Donta ST
J Infect Dis; 1974 Mar; 129(3):284-8. PubMed ID: 4593242
[No Abstract] [Full Text] [Related]
9. [Effect of revaccination in persons inoculated primarily with whole-cell and toxoid cholera vaccines].
Kiseleva IE; Domaradskiĭ IV; Erokhin EP; Kirdeev VK; Kiseleva VI
Zh Mikrobiol Epidemiol Immunobiol; 1974 Jun; 51(6):64-7. PubMed ID: 4409388
[No Abstract] [Full Text] [Related]
10. Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum.
Cash RA; Music SI; Libonati JP; Snyder MJ; Wenzel RP; Hornick RB
J Infect Dis; 1974 Jan; 129(1):45-52. PubMed ID: 4809112
[No Abstract] [Full Text] [Related]
11. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R
Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509
[TBL] [Abstract][Full Text] [Related]
12. Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity.
Levine MM; Nalin DR; Craig JP; Hoover D; Bergquist EJ; Waterman D; Holley HP; Hornick RB; Pierce NP; Libonati JP
Trans R Soc Trop Med Hyg; 1979; 73(1):3-9. PubMed ID: 442179
[TBL] [Abstract][Full Text] [Related]
13. Intraduodenal inoculation of adult rabbits for evaluating the immunogenicity of genetically attenuated Vibrio cholerae strains.
García Imia L; Oliva Hernández R; Cedré Marrero B; Valmaseda Pérez T; García Sánchez H; Talavera Coronel A; Pérez Quiñoy JL; Sierra González G
Lab Anim Sci; 1998 Oct; 48(5):538-41. PubMed ID: 10090073
[No Abstract] [Full Text] [Related]
14. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.
Svennerholm AM; Jertborn M; Gothefors L; Karim AM; Sack DA; Holmgren J
J Infect Dis; 1984 Jun; 149(6):884-93. PubMed ID: 6736680
[TBL] [Abstract][Full Text] [Related]
15. Immunity to experimental cholera. I. Protective effect of humoral IgG antitoxin demonstrated by passive immunization.
Pierce NF; Reynolds HY
J Immunol; 1974 Sep; 113(3):1017-23. PubMed ID: 4413777
[No Abstract] [Full Text] [Related]
16. Brucella antibodies and oral cholera vaccination.
Begue RE; Guillen A; Meza R
Lancet; 1995 Jul; 346(8967):115-6. PubMed ID: 7603186
[No Abstract] [Full Text] [Related]
17. Sensitive microplate assay for detection of bactericidal antibodies to Vibrio cholerae O139.
Attridge SR; Johansson C; Trach DD; Qadri F; Svennerholm AM
Clin Diagn Lab Immunol; 2002 Mar; 9(2):383-7. PubMed ID: 11874883
[TBL] [Abstract][Full Text] [Related]
18. Live oral cholera vaccine: evaluation of the clinical effectiveness of two strains in humans.
Cash RA; Music SI; Libonati JP; Schwartz AR; Hornick RB
Infect Immun; 1974 Oct; 10(4):762-4. PubMed ID: 4426706
[TBL] [Abstract][Full Text] [Related]
19. Immunity in experimental cholera: effect of parenteral immunization with vaccines and toxoid.
Sinha VB; Bhaskaran K
Bull World Health Organ; 1973; 49(6):605-13. PubMed ID: 4548387
[TBL] [Abstract][Full Text] [Related]
20. Protection against experimental cholera by antitoxin.
Pierce NF; Kaniecki EA; Northrup RS
J Infect Dis; 1972 Dec; 126(6):606-16. PubMed ID: 4664117
[No Abstract] [Full Text] [Related]
[Next] [New Search]
